News

2022

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering Unveils ProFound™ Therapeutics to Illuminate an Expanded Universe of Human Proteins with the Potential to Enable a Multitude of New Medicines

ProFound™ Therapeutics 05.26.2022

Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock

Evelo Biosciences 05.25.2022

Flagship Pioneering Unveils Sonata Therapeutics to Harness Cellular Microenvironments for the Treatment of Serious Diseases

Sonata Therapeutics 05.18.2022

Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Evelo Biosciences 05.12.2022

Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines

05.10.2022

Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

Valo 04.27.2022

Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors

Evelo Biosciences 04.21.2022

Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform

Tessera Therapeutics 04.19.2022

Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner

04.13.2022

Flagship Pioneering Bolsters Executive Team with Appointment of Michelle C. Werner as CEO-Partner and CEO of Alltrna

04.11.2022

Loading